Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure
- 28 February 2005
- journal article
- case report
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (2) , 279-281
- https://doi.org/10.1016/j.jhep.2004.09.017
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆Gastroenterology, 2004
- Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virusGastroenterology, 2004
- Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B1Gastroenterology, 2004
- Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patientJournal of Hepatology, 2003
- Treatment of pre- and post-liver transplantation HBV infection: Should we aim at combination therapy?Hepatology, 2003
- Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymeraseGastroenterology, 2003
- Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis BClinical Infectious Diseases, 2003
- Viral Clearance Without Destruction of Infected Cells During Acute HBV InfectionScience, 1999
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998